Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-50167
J Mol Cell Cardiol 2015 Apr 01;81:71-80. doi: 10.1016/j.yjmcc.2015.01.017.
Show Gene links Show Anatomy links

TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes.

Rinné S , Kiper AK , Schlichthörl G , Dittmann S , Netter MF , Limberg SH , Silbernagel N , Zuzarte M , Moosdorf R , Wulf H , Schulze-Bahr E , Rolfes C , Decher N .


???displayArticle.abstract???
TASK-1 channels have emerged as promising drug targets against atrial fibrillation, the most common arrhythmia in the elderly. While TASK-3, the closest relative of TASK-1, was previously not described in cardiac tissue, we found a very prominent expression of TASK-3 in right human auricles. Immunocytochemistry experiments of human right auricular cardiomyocytes showed that TASK-3 is primarily localized at the plasma membrane. Single-channel recordings of right human auricles in the cell-attached mode, using divalent-cation-free solutions, revealed a TASK-1-like channel with a single-channel conductance of about 30pS. While homomeric TASK-3 channels were not found, we observed an intermediate single-channel conductance of about 55pS, possibly reflecting the heteromeric channel formed by TASK-1 and TASK-3. Subsequent experiments with TASK-1/TASK-3 tandem channels or with co-expressed TASK-1 and TASK-3 channels in HEK293 cells or Xenopus oocytes, supported that the 55pS channels observed in right auricles have electrophysiological characteristics of TASK-1/TASK-3 heteromers. In addition, co-expression experiments and single-channel recordings suggest that heteromeric TASK-1/TASK-3 channels have a predominant surface expression and a reduced affinity for TASK-1 blockers. In summary, the evidence for heteromeric TASK-1/TASK-3 channel complexes together with an altered pharmacologic response to TASK-1 blockers in vitro is likely to have further impact for studies isolating ITASK-1 from cardiomyocytes and for the development of drugs specifically targeting TASK-1 in atrial fibrillation treatment.

???displayArticle.pubmedLink??? 25655935
???displayArticle.link??? J Mol Cell Cardiol


Species referenced: Xenopus laevis
Genes referenced: kcnk3 kcnk9

???displayArticle.disOnts??? atrial fibrillation